1 unknown. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
Follow Yi Miao: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System Recombinant Human Interleukin-2, HER2Bi-Armed T Cells - Esophageal Cancer, Gastric Cancer | Phase 1 | Unknown | Yi Miao | 6 | 2016-02-01 | 2016-01-25 |
Esophageal Neoplasms (1) · Gallbladder Neoplasms (1) · Intestinal Neoplasms (1) · Liver Neoplasms (1) · Pancreatic Neoplasms (1) · Stomach Neoplasms (1)
aldesleukin (1)
China (1)